Pseudohypoparathyroidism is rare during pregnancy and poses multiple challenges related to its diagnosis and management during pregnancy. We hereby report a case of a young woman who was diagnosed to have type 1a pseudohypoparathyroidism. She was managed by multidisciplinary team and had good maternal and perinatal outcome. Management-related issues are discussed here in detail.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388577PMC
http://dx.doi.org/10.1155/2012/629583DOI Listing

Publication Analysis

Top Keywords

management pseudohypoparathyroidism
4
pseudohypoparathyroidism type
4
type pregnancy
4
pregnancy labor
4
labor case
4
case report
4
report pseudohypoparathyroidism
4
pseudohypoparathyroidism rare
4
rare pregnancy
4
pregnancy poses
4

Similar Publications

Summary: Short stature is a common complaint among pediatric visits and the differential diagnosis is extensive. Although some variations in growth are normal, deviation from normal growth is often the first symptom of chronic disease in children. This is true for hormone abnormalities including growth hormone deficiency, hypothyroidism and glucocorticoid excess.

View Article and Find Full Text PDF

Genotype-Phenotype Correlation of GNAS Gene: Review and Disease Management of a Hotspot Mutation.

Int J Mol Sci

October 2024

Medical and Laboratory Genetics Unit, A.O.R.N. "Antonio Cardarelli", 80131 Naples, Italy.

Article Synopsis
  • Defects in a specific gene are primarily linked to pseudohypoparathyroidism Ia (PHP1a), with various mutation types identified across all 13 exons.
  • A noteworthy mutation, a 4 bp deletion c.565_568delGACT, is recognized as a mutation hotspot, though focused studies on this variant have been limited.
  • The authors reported two PHP1a cases related to this deletion and found that patients with the c.565_568delGACT mutation exhibited a higher prevalence of certain characteristics—like brachydactyly and intellectual disability—compared to those with other mutations, suggesting a need for tailored patient monitoring.
View Article and Find Full Text PDF
Article Synopsis
  • This report investigates a family with familial isolated hypoparathyroidism (FIH), highlighting a specific mutation that leads to high levels of functionally inactive parathyroid hormone (PTH) in a 34-year-old woman and her siblings.* -
  • The siblings were diagnosed with pseudohypoparathyroidism type 1b, characterized by chronic low calcium levels and elevated PTH, but without the typical features of related disorders.* -
  • Treatment with teriparatide, a recombinant human PTH, successfully normalized calcium levels and improved wellbeing for the patient, indicating that inactive variants of PTH can lead to complex hypocalcemia cases.*
View Article and Find Full Text PDF
Article Synopsis
  • Pseudohypoparathyroidism (PHP) is a disorder where the body is resistant to parathyroid hormone, causing high PTH levels, low calcium, and high phosphate, leading to various health issues.
  • The most common subtype, PHP type 1a, causes symptoms like short stature and electrolyte imbalances, which can result in conditions like seizures or fractures.
  • A case study of a 22-year-old woman with PHP highlights her severe symptoms, diagnosis process, and treatment plan, including calcium and Vitamin D supplementation after managing her fractures.
View Article and Find Full Text PDF

Characterization of Digestive Manifestations in Patients with Impaired PTH/PTHrP Signaling Disorder/Pseudohypoparathyroidism.

Horm Res Paediatr

August 2024

Pediatric Nutrition and Gastroenterology Department, Reference Center for Rare Disorders, PRADORT (Syndrome de PRADer-Willi et autres Obésités Rares avec Troubles du comportement alimentaire), Trousseau Hospital, AP-HP, Sorbonne University, Paris, France.

Article Synopsis
  • Pseudohypoparathyroidism is a rare condition linked to issues with the GNAS gene, leading to resistance to certain hormones and symptoms like short stature, obesity, and ossifications.
  • This study aimed to investigate the frequency of digestive problems, particularly constipation, in children with iPPSD types 2 and 3, involving 36 patients aged 2 to 18 years.
  • Results revealed that over 60% of participants reported constipation, with only a small percentage finding treatment effective, while other digestive issues like vomiting and food selectivity were also common.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!